Related Experiment Video
Updated: Jun 13, 2026

Electrocardiogram Recordings in Anesthetized Mice using Lead II
Published on: June 20, 2020
Lithium-associated Mobitz II block: case series and review of the literature
Ehrin J Armstrong1, Ankit Dubey, Melvin M Scheinman
1Department of Medicine, Division of Cardiology, University of California, San Francisco, California 94143-0124, USA. ehrin.armstrong@gmail.com
Abstract:
We report two cases of lithium-associated Mobitz II block. Both patients required placement of a permanent pacemaker due to persistent block and symptoms despite attempts at lowering the daily dose of lithium. We then reviewed the literature on this rare complication. Chronic lithium therapy may be associated with development of conduction block at or below the level of the atrioventricular node. Patients taking lithium should be monitored closely for development of cardiovascular complications.
Related Concept Videos
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Mania and Antimanic Drugs: Overview
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Depolarizing Blockers: Mechanism of Action
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
